38
Views
0
CrossRef citations to date
0
Altmetric
Conference Report

Biomathematical modeling and cancer immunotherapy: report of the workshop held at Bol, Island of Brač, Croatia, 20–21 June 2011

Pages 144-146 | Received 06 Aug 2011, Accepted 06 Sep 2011, Published online: 24 Oct 2011
 

Abstract

At the end of June 2011, mathematicians, physicians and biomedical scientists met for a 2-day workshop at Bol, Island of Brač, Croatia. The purpose of the event was to evaluate the role of mathematical models as practical tools for optimizing cancer immunotherapy. Participants reviewed recent advances in the field and addressed potential causes of the lack of predictable clinical outcomes. They agreed that there is a need for treatments tailored to the individual patient based on the patient's ability to respond. Dynamic mathematical models based on the available understanding of interactions between the tumor, immunity and therapeutic intervention and ‘trained’ on the actual clinical data could help stratify patients before treatment and predict individual responses to ongoing treatment. In addition, mathematical models could assist in selecting the most beneficial individualized treatment modifications. Participants established a collaborative network to test some of the ideas discussed at the workshop and decided to review progress at the next meeting in Croatia in 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.